CHIOU-YAN LAI: Open Payments
NPI 1801347901 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 38 payments from 16 companies in 2025. Trend: 2023 $186 · 2024 $390 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $163 |
| PFIZER INC. | 3 | $73 |
| Astellas Pharma US Inc | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
Products named: PREVNAR 20, Veozah, TRELEGY ELLIPTA, Ozempic, Rybelsus, VRAYLAR, MOUNJARO, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
